ES2088011T3 - Antagonistas de aminoacidos excitadores. - Google Patents

Antagonistas de aminoacidos excitadores.

Info

Publication number
ES2088011T3
ES2088011T3 ES91913891T ES91913891T ES2088011T3 ES 2088011 T3 ES2088011 T3 ES 2088011T3 ES 91913891 T ES91913891 T ES 91913891T ES 91913891 T ES91913891 T ES 91913891T ES 2088011 T3 ES2088011 T3 ES 2088011T3
Authority
ES
Spain
Prior art keywords
amino acid
acid antagonists
exciting amino
exciting
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91913891T
Other languages
English (en)
Inventor
Francesco G Salituro
Bruce M Baron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2088011T3 publication Critical patent/ES2088011T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

EL PRESENTE INVENTO SE REFIERE A UN NUEVO GRUPO DE DERIVADOS DE INDOL QUE SON ANTAGONISTAS DE NMDA.
ES91913891T 1990-07-16 1991-06-17 Antagonistas de aminoacidos excitadores. Expired - Lifetime ES2088011T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55605790A 1990-07-16 1990-07-16

Publications (1)

Publication Number Publication Date
ES2088011T3 true ES2088011T3 (es) 1996-08-01

Family

ID=24219725

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91913891T Expired - Lifetime ES2088011T3 (es) 1990-07-16 1991-06-17 Antagonistas de aminoacidos excitadores.

Country Status (15)

Country Link
US (1) US5106847A (es)
EP (1) EP0539503B1 (es)
JP (1) JP3058688B2 (es)
KR (1) KR0178469B1 (es)
AT (1) ATE136295T1 (es)
AU (1) AU646686B2 (es)
CA (1) CA2087091C (es)
DE (1) DE69118539T2 (es)
DK (1) DK0539503T3 (es)
ES (1) ES2088011T3 (es)
FI (1) FI98455C (es)
GR (1) GR3019689T3 (es)
HU (1) HU216787B (es)
NO (1) NO179249C (es)
WO (1) WO1992001670A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189054A (en) * 1990-11-02 1993-02-23 Merrell Dow Pharmaceuticals Inc. 3-amidoindolyl derivatives and pharmaceutical compositions thereof
US5318985A (en) * 1991-12-20 1994-06-07 Merrell Dow Pharmaceuticals Inc. Potentiation of NMDA antagonists
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
USRE39300E1 (en) 1993-01-28 2006-09-19 Virginia Commonwealth University Medical College Of Virginia Inhibiting the development of tolerance to and/or dependence on an addictive substance
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
TW280819B (es) * 1993-11-17 1996-07-11 Sumitomo Pharma
US5783575A (en) * 1994-03-14 1998-07-21 Novo Nordisk A/S Antagonists, their preparation and use
US5696148A (en) * 1994-03-14 1997-12-09 Novo Nordisk A/S Indole compounds and their use in treating diseases of the central nervous system
US5563157B1 (en) 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
GB9502695D0 (en) * 1995-02-11 1995-03-29 Glaxo Spa Pharmaceutical composition
JPH11509847A (ja) * 1995-07-31 1999-08-31 ノボ ノルディスク アクティーゼルスカブ ヘテロ環式化合物、それらの調製及び使用
KR20000048715A (ko) * 1996-09-30 2000-07-25 게리 디. 스트리트, 스티븐 엘. 네스비트 Ｎｍｄａ (ｎ-메틸-ｄ-아스파르테이트) 길항제
ES2230676T3 (es) 1997-03-14 2005-05-01 Smithkline Beecham Corporation Nuevos indolcarboxamidas, composiciones farmaceuticas y procedimientos de inhibicion de la calpaina.
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
US7375136B2 (en) * 2001-03-08 2008-05-20 Emory University pH-dependent NMDA receptor antagonists
US20030162825A1 (en) * 2001-11-09 2003-08-28 Sepracor Inc. D-amino acid oxidase inhibitors for learning and memory
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US8420680B2 (en) * 2007-06-29 2013-04-16 Emory University NMDA receptor antagonists for neuroprotection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960786A (en) * 1989-04-24 1990-10-02 Merrell Dow Pharmaceuticals Inc. Excitatory amino acid antagonists
JPH0347123A (ja) * 1989-05-05 1991-02-28 G D Searle & Co インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物
AU8641991A (en) * 1990-09-10 1992-03-30 Rhone-Poulenc Rorer International (Holdings) Inc. Substituted bicyclic aryl compounds exhibiting selective leukotriene b4 antagonist activity
WO1993005020A1 (en) * 1991-09-06 1993-03-18 Merck & Co., Inc. Indoles as inhibitors of hiv reverse transcriptase

Also Published As

Publication number Publication date
FI98455C (fi) 1997-06-25
EP0539503A1 (en) 1993-05-05
WO1992001670A1 (en) 1992-02-06
ATE136295T1 (de) 1996-04-15
US5106847A (en) 1992-04-21
NO179249B (no) 1996-05-28
GR3019689T3 (en) 1996-07-31
DE69118539T2 (de) 1996-09-19
HU9300100D0 (en) 1993-04-28
AU646686B2 (en) 1994-03-03
EP0539503B1 (en) 1996-04-03
CA2087091C (en) 2001-09-11
JP3058688B2 (ja) 2000-07-04
HU216787B (hu) 1999-08-30
DK0539503T3 (da) 1996-05-13
NO930035L (no) 1993-01-07
AU8290891A (en) 1992-02-18
DE69118539D1 (de) 1996-05-09
JPH05508857A (ja) 1993-12-09
EP0539503A4 (es) 1994-03-23
KR0178469B1 (ko) 1999-03-20
CA2087091A1 (en) 1992-01-17
FI930150A (fi) 1993-01-14
HUT67237A (en) 1995-03-28
NO930035D0 (no) 1993-01-07
FI930150A0 (fi) 1993-01-14
NO179249C (no) 1996-09-04
FI98455B (fi) 1997-03-14

Similar Documents

Publication Publication Date Title
ES2088011T3 (es) Antagonistas de aminoacidos excitadores.
ES2052704T3 (es) Analogos de benzodiacepina.
ES2078257T3 (es) Antagonistas de aminoacidos excitantes.
FI961628A (fi) Indolijohdannaisia NMDA-antagonisteina
ATE119882T1 (de) 3-indolyl thioacetat derivate.
DK0508796T3 (da) Cholecystokonin-antagonister
FI953361A (fi) Menetelmä substituoitujen indolonijohdannaisten valmistamiseksi
ES2089511T3 (es) Dihidroquinolina antagonistas de nmda.
GR1001309B (el) Μεθοδος παρασκευης παραγωγου ενωσεως της διχλωροανιλινης.
EE9900257A (et) Protsess NMDA antagonistide valmistamiseks
DK0613459T3 (da) N-Tritylasparaginsyrederivater til fremstilling af phosphonat NMDA antagonister

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 539503

Country of ref document: ES